Promis Neurosciences (Germany) Technical Analysis
| 23J Stock | EUR 13.40 0.20 1.47% |
As of the 7th of February, Promis Neurosciences holds the Semi Deviation of 3.71, coefficient of variation of 746.37, and Risk Adjusted Performance of 0.1166. Promis Neurosciences technical analysis gives you tools to exploit past prices in attempt to determine a pattern that determines the direction of the company's future prices. Please check Promis Neurosciences downside deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance to decide if Promis Neurosciences is priced some-what accurately, providing market reflects its current price of 13.4 per share.
Promis Neurosciences Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Promis, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to PromisPromis |
Promis Neurosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Promis Neurosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Promis Neurosciences.
| 11/09/2025 |
| 02/07/2026 |
If you would invest 0.00 in Promis Neurosciences on November 9, 2025 and sell it all today you would earn a total of 0.00 from holding Promis Neurosciences or generate 0.0% return on investment in Promis Neurosciences over 90 days. Promis Neurosciences is related to or competes with AUREA SA, Superior Plus, Intel, Volkswagen, Bitwise Core, Rolls-Royce Holdings, and Reliance Steel. ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative di... More
Promis Neurosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Promis Neurosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Promis Neurosciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.64 | |||
| Information Ratio | 0.1192 | |||
| Maximum Drawdown | 23.41 | |||
| Value At Risk | (7.19) | |||
| Potential Upside | 14.77 |
Promis Neurosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Promis Neurosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Promis Neurosciences' standard deviation. In reality, there are many statistical measures that can use Promis Neurosciences historical prices to predict the future Promis Neurosciences' volatility.| Risk Adjusted Performance | 0.1166 | |||
| Jensen Alpha | 0.9 | |||
| Total Risk Alpha | 0.2025 | |||
| Sortino Ratio | 0.1553 | |||
| Treynor Ratio | (0.64) |
Promis Neurosciences February 7, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1166 | |||
| Market Risk Adjusted Performance | (0.63) | |||
| Mean Deviation | 4.33 | |||
| Semi Deviation | 3.71 | |||
| Downside Deviation | 4.64 | |||
| Coefficient Of Variation | 746.37 | |||
| Standard Deviation | 6.05 | |||
| Variance | 36.63 | |||
| Information Ratio | 0.1192 | |||
| Jensen Alpha | 0.9 | |||
| Total Risk Alpha | 0.2025 | |||
| Sortino Ratio | 0.1553 | |||
| Treynor Ratio | (0.64) | |||
| Maximum Drawdown | 23.41 | |||
| Value At Risk | (7.19) | |||
| Potential Upside | 14.77 | |||
| Downside Variance | 21.57 | |||
| Semi Variance | 13.75 | |||
| Expected Short fall | (6.08) | |||
| Skewness | 1.19 | |||
| Kurtosis | 1.38 |
Promis Neurosciences Backtested Returns
Promis Neurosciences is slightly risky given 3 months investment horizon. Promis Neurosciences maintains Sharpe Ratio (i.e., Efficiency) of 0.17, which implies the firm had a 0.17 % return per unit of risk over the last 3 months. We were able to interpolate twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.03% are justified by taking the suggested risk. Use Promis Neurosciences Risk Adjusted Performance of 0.1166, coefficient of variation of 746.37, and Semi Deviation of 3.71 to evaluate company specific risk that cannot be diversified away. Promis Neurosciences holds a performance score of 13 on a scale of zero to a hundred. The company holds a Beta of -1.24, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Promis Neurosciences are expected to decrease by larger amounts. On the other hand, during market turmoil, Promis Neurosciences is expected to outperform it. Use Promis Neurosciences downside deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to analyze future returns on Promis Neurosciences.
Auto-correlation | -0.2 |
Insignificant reverse predictability
Promis Neurosciences has insignificant reverse predictability. Overlapping area represents the amount of predictability between Promis Neurosciences time series from 9th of November 2025 to 24th of December 2025 and 24th of December 2025 to 7th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Promis Neurosciences price movement. The serial correlation of -0.2 indicates that over 20.0% of current Promis Neurosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.2 | |
| Spearman Rank Test | -0.59 | |
| Residual Average | 0.0 | |
| Price Variance | 5.57 |
Promis Neurosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Promis Neurosciences Technical Analysis
The output start index for this execution was fifty with a total number of output elements of eleven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Promis Neurosciences volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Promis Neurosciences Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Promis Neurosciences on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Promis Neurosciences based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Promis Neurosciences price pattern first instead of the macroeconomic environment surrounding Promis Neurosciences. By analyzing Promis Neurosciences's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Promis Neurosciences's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Promis Neurosciences specific price patterns or momentum indicators. Please read more on our technical analysis page.
Promis Neurosciences February 7, 2026 Technical Indicators
Most technical analysis of Promis help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Promis from various momentum indicators to cycle indicators. When you analyze Promis charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1166 | |||
| Market Risk Adjusted Performance | (0.63) | |||
| Mean Deviation | 4.33 | |||
| Semi Deviation | 3.71 | |||
| Downside Deviation | 4.64 | |||
| Coefficient Of Variation | 746.37 | |||
| Standard Deviation | 6.05 | |||
| Variance | 36.63 | |||
| Information Ratio | 0.1192 | |||
| Jensen Alpha | 0.9 | |||
| Total Risk Alpha | 0.2025 | |||
| Sortino Ratio | 0.1553 | |||
| Treynor Ratio | (0.64) | |||
| Maximum Drawdown | 23.41 | |||
| Value At Risk | (7.19) | |||
| Potential Upside | 14.77 | |||
| Downside Variance | 21.57 | |||
| Semi Variance | 13.75 | |||
| Expected Short fall | (6.08) | |||
| Skewness | 1.19 | |||
| Kurtosis | 1.38 |
Promis Neurosciences February 7, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Promis stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.01 | ||
| Daily Balance Of Power | (2.00) | ||
| Rate Of Daily Change | 0.99 | ||
| Day Median Price | 13.45 | ||
| Day Typical Price | 13.43 | ||
| Price Action Indicator | (0.15) | ||
| Market Facilitation Index | 0.10 |
Complementary Tools for Promis Stock analysis
When running Promis Neurosciences' price analysis, check to measure Promis Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Promis Neurosciences is operating at the current time. Most of Promis Neurosciences' value examination focuses on studying past and present price action to predict the probability of Promis Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Promis Neurosciences' price. Additionally, you may evaluate how the addition of Promis Neurosciences to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |